InvestorsHub Logo
Followers 8
Posts 1542
Boards Moderated 0
Alias Born 06/21/2007

Re: A deleted message

Thursday, 02/02/2023 9:06:08 PM

Thursday, February 02, 2023 9:06:08 PM

Post# of 13622
lets take a look at what we know??
As described in its October 31 press release, the Company has Completed its review and documentation of Manufacturing and Packaging related Standard Operating Procedures.(SOPs) and is now awaiting external laboratory test resullts on Hemostyp samples produced under its new manufacturing arrangement..Upon receipt and review of the sample analysis, the company (expects) to submit its full PMA application within a few days. Update of 28 November,2022..

Dec.19, 2022---UHP continues to advance its, PMA Application with the FDA.. the company has received and reviewed external laboratory test results on the Hemostyp gauze product under its new manufacturing arrangement. The measured physical and chemical characteristics of the new product were shown to be effectively identicalto those of the Hemostyp gause product utilized in the company's human trial, (a Key step towards demonstrating a supply of equivalent product)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent UEEC News